Charcot-Marie-Tooth disease (CMT) is a genetically heterogeneous group of inherited disorders characterized by severe peripheral neuropathy, affecting myelinated motor and sensory axons and leading to distal muscle weakness and atrophy. Among the recessive demyelinating neuropathies (CMT4), three have been found to result from defects in enzymes of phosphoinositide metabolism. CMT4B-1 and -2 exhibit mutations in members of the myotubularin family of PI 3-phosphatases, MTMR2 and MTMR13, respectively, whereas CMT4J exhibits mutations in SAC3 (homolog of yeast FIG4), a PI(3,5)P 2 5-phosphatase (Scherer et al., 2008) . A unique aspect of the MTM family is that nearly half of its members are catalytically inactive. Several of the latter have been found to play important roles in MTMs are localized to endosomal compartments, underscoring their role in control of PI3P/PI(3,5)P 2 signaling which is important for trafficking through the endosomal system (Nicot et al., 2008) . Further indication that PI3P/PI(3,5)P 2 play a crucial role in myelinating Schwann cells is provided by the discovery that CMT4J is caused by mutations in the 5-phosphatase, SAC3. The latter forms a complex with PIKfyve (a PI3P-5kinase), leading to its activation and production of PI(3,5)P 2 (Liu et al., 2010) . Thus, paradoxically, loss of SAC3 (which converts
